FDA Warns Against Use of Terbutaline to Treat Pre-Term Labor

 

FDA's warning on terbutaline: "The U.S. Food and Drug Administration (FDA) is warning the public that injectable terbutaline should not be used in pregnant women for prevention or prolonged treatment (beyond 48-72 hours) of preterm labor in either the hospital or outpatient setting because of the potential for serious maternal heart problems and death."

 

http://www.fda.gov/Drugs/DrugSafety/ucm243539.htm?sms_ss=facebook&a...

 

Tags: fda, labor, preterm, terbutaline, warning

Views: 1

Reply to This

FOLLOW US ON

Follow My Best Birth on Twitter or join us on Facebook.

Sponsors











© 2014   Created by MyBestBirth Admin.

Badges  |  Report an Issue  |  Terms of Service